BCL6 is an oncogene that functions as a transcriptional repressor necessary for GC formation (Cattoretti et al., 2005), being expressed 60%‐80% of PCNSL (Montesinos‐Rongen et al., 2008). The gene discussed is BCL6; the disease is primary central nervous system lymphoma.